Amgen
Manufacturing · California, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
1 Amgen Center Dr, Thousand Oaks, Califo...Phone Number
(805) 447-1000Website
www.amgen.comRevenue
$37.2 BillionStock Symbol
AMGNIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
4
3
4
2
2
About Amgen
Amgen Inc. (Nasdaq: AMGN) is a leading American multinational biotechnology company headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the biotech industry and remains at the forefront of scientific innovation.Explore more
Amgen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amgen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Amgen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Amgen
Click to see if Amgen had a recent Job posting/layoffs
Check out if Amgen is spiking on competitors!
Earning: See what the market has to say on Amgen recently announced quarterly report
Amgen, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Amgen has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Amgen launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Amgen
Compare insights from companies similar to Amgen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$58.7B
10K+
Public
$4.7B
1999
DA
David AuerbachStrategy, Transformation Operations Leader & Global Chief Operating Officer, Head of Tmo, Oncology Research & Development
$29.7B
10K+
Public
$296.3M
1987
CD
Courtney DesmondChief of Staff To Senior Vice President Chief Ethics and Compliance Officer
Company Profile Activity
Activity Insights
Amgen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amgen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amgen.
Amgen financials insights
Gather financial insights about Amgen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1980
Debt
$19M
2022
Debt
$2B
Amgen Tech Stack
A closer look at the technologies used by Amgen
See more technologies
Most Recent Scoops
Person-Based
Partnership, Medical Research
Person-Based
Partnership, Medical Research
Open Position
Layoffs
Layoffs
Open Position
Amgen News & Media
Amgen Q2 2026 earnings beat, raises full-year outlook, drops AMG 513
The biotech raised its full-year revenue forecast to $38.2 billion–$39.4 billion after second-quarter revenue rose 10% to $10.1 billionAmgen Q2 Earnings Call Highlights
Amgen (NASDAQ:AMGN) reported second-quarter revenue above $10 billion, up 10% from a year earlier, as growth across several key medicines offset competitive pressure on its bone-health franchise. The company raised its full-year revenue and adjusted earnings outlook while continuing to increase spenAmgen second-quarter sales rise 9%, profit tops Street view
By Deena Beasley Aug 3 (Reuters) - Amgen on Tuesday reported second-quarter sales rose 9%, driven by demand for cholesterol drug Repatha, bone drug Evenity and medications for rare diseases, as theAMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
THOUSAND OAKS, Calif., Aug. 4, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2026. "Our results demonstrate strong performance across our business. Our six key growth drivers grew 26% year over year, generating nearly 70% of...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amgen
Sign Up For FreeTo access detailed company insights
Amgen Inc. (Nasdaq: AMGN) is a leading American multinational biotechnology company headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the biotech industry and remains at the forefront of scientific innovation.... Read More
